These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 7785662)
1. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Weissmann DJ; Ferry JA; Harris NL; Louis DN; Delmonico F; Spiro I Am J Clin Pathol; 1995 Jun; 103(6):748-55. PubMed ID: 7785662 [TBL] [Abstract][Full Text] [Related]
2. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation. Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322 [TBL] [Abstract][Full Text] [Related]
3. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Chadburn A; Suciu-Foca N; Cesarman E; Reed E; Michler RE; Knowles DM Am J Pathol; 1995 Dec; 147(6):1862-70. PubMed ID: 7495309 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin. Peterson MR; Emery SC; Yung GL; Masliah E; Yi ES Arch Pathol Lab Med; 2006 Feb; 130(2):176-80. PubMed ID: 16454557 [TBL] [Abstract][Full Text] [Related]
5. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children. Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052 [TBL] [Abstract][Full Text] [Related]
6. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin. Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335 [TBL] [Abstract][Full Text] [Related]
7. Post-transplant lymphoproliferative disorders: determination of donor/recipient origin in a large cohort of kidney recipients. Olagne J; Caillard S; Gaub MP; Chenard MP; Moulin B Am J Transplant; 2011 Jun; 11(6):1260-9. PubMed ID: 21564528 [TBL] [Abstract][Full Text] [Related]
8. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy. Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG; Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361 [TBL] [Abstract][Full Text] [Related]
9. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation. Petit B; Le Meur Y; Jaccard A; Paraf F; Robert CL; Bordessoule D; Labrousse F; Drouet M Transplantation; 2002 Jan; 73(2):265-71. PubMed ID: 11821742 [TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997 [TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124 [TBL] [Abstract][Full Text] [Related]
12. Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009. Yoon SO; Yu E; Cho YM; Suh C; Kim KM; Han DJ; Lee SG; Huh J Clin Transplant; 2012; 26(1):67-73. PubMed ID: 21269330 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of early and late PTLD development in pediatric solid organ transplant recipients. Schober T; Framke T; Kreipe H; Schulz TF; Großhennig A; Hussein K; Baumann U; Pape L; Schubert S; Wingen AM; Jack T; Koch A; Klein C; Maecker-Kolhoff B Transplantation; 2013 Jan; 95(1):240-6. PubMed ID: 23222898 [TBL] [Abstract][Full Text] [Related]
14. Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin. Ng IO; Shek TW; Thung SN; Ye MM; Lo CM; Fan ST; Lee JM; Chan KW; Cheung AN Mod Pathol; 2000 Nov; 13(11):1180-5. PubMed ID: 11106074 [TBL] [Abstract][Full Text] [Related]
15. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients. Preiksaitis JK Clin Infect Dis; 2004 Oct; 39(7):1016-23. PubMed ID: 15472855 [TBL] [Abstract][Full Text] [Related]
16. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients. Lim GY; Newman B; Kurland G; Webber SA Radiology; 2002 Mar; 222(3):699-708. PubMed ID: 11867788 [TBL] [Abstract][Full Text] [Related]
17. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Orazi A; Hromas RA; Neiman RS; Greiner TC; Lee CH; Rubin L; Haskins S; Heerema NA; Gharpure V; Abonour R; Srour EF; Cornetta K Am J Clin Pathol; 1997 Apr; 107(4):419-29. PubMed ID: 9124210 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey. Khedmat H; Taheri S Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272 [TBL] [Abstract][Full Text] [Related]